Nvidia invests $2bn in chipmaker Marvell to boost AI networking
Semiconductor groups join forces on silicon photonics to speed up data centre systems
Nvidia invests $2bn in chipmaker Marvell to boost AI networking
Semiconductor groups join forces on silicon photonics to speed up data centre systems
FilterFinancial Times
Clustered coverageFinancial Times
Coverage timeline1
Coverage timeline
Coverage timeline
Ranked reports inside the event cluster. Open any publisher link to read the original coverage.
Related events
Related events
Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.
1 report1 sourceSimilarity 0.38
Marvell stock pops 13% as Nvidia takes $2 billion stake, continuing run of similar bets
Nvidia has also made $2 billion investments in CoreWeave, Nebius and Coherent in recent months.
CNBC
1 report1 sourceSimilarity 0.28
Here is why Nvidia's partnership and investment in Marvell is such a big deal
Nvidia's deal with Marvell Technology is yet another reason to stick with the AI giant's sluggish stock.
CNBC
19 reports8 sourcesSimilarity 0.14
China is trying to play peacemaker in the Iran war - will it work?
It's a turnaround for Beijing, whose official response has been muted so far. Why is China stepping in now? Grouped from 19 articles across 8 sources.
Al Jazeera, BBC News, CNBC +5
1 report1 sourceSimilarity 0.10
These old sugarcane farms could be turned into rainforest again
A conservation group's plans to replant species from the World Heritage-listed Daintree Rainforest on land used for growing sugar have not won everybody over.
ABC Australia
3 reports3 sourcesSimilarity 0.09
Trump signs executive order limiting mail-in voting ahead of 2026 U.S. elections
Trump has put pressure on Congress to pass the SAVE America Act, a measure that would require photo identification and proof of U.S. citizenship to vote. Grouped from 3 articles across 3 sources.
CNBC, The Guardian, The Straits Times
1 report1 sourceSimilarity 0.09
Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs
Centessa is one of several companies working on a new class of drugs to treat narcolepsy, a condition that makes it difficult for people to stay awake.
CNBC